Soleno Therapeutics (SLNO) Q1 2023 Earnings

9MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.91
-0.8
-0.69
-0.58

Details

Expected EPS
-0.72
Actual EPS
-0.88
Surprise EPS
-0.16
Surprise Percent
+22.22%

Description

Soleno Therapeutics (SLNO) has reported earnings of -0.88 per share for Q1 2023.

0 Comments

Share your thoughts